Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Kanako SUGAWARA"'
Publikováno v:
AMB Express, Vol 9, Iss 1, Pp 1-8 (2019)
Abstract Alizarin is an anti-fungal compound produced by the plant, Rubia tinctorum. The parasitic fungus Bjerkandera adusta Dec 1 was cultured in potato dextrose (PD) medium with or without alizarin. Alizarin was a good substrate for the dye-decolor
Externí odkaz:
https://doaj.org/article/07ef62b7fc224e4093926a882561220c
Autor:
Kanako Sugawara, Toru Yoshida, Rena Hirashima, Ryoko Toriumi, Hotaka Akiyama, Yurika Kakuta, Yuki Ishige, Yasushi Sugano
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 16, p 8683 (2021)
DyP-type peroxidases are a family of heme peroxidases named for their ability to degrade persistent anthraquinone dyes. DyP-type peroxidases are subclassified into three classes: classes P, I and V. Based on its genome sequence, Streptomyces avermiti
Externí odkaz:
https://doaj.org/article/de529c795912422c9766e1b39ce49427
Publikováno v:
AMB Express, Vol 9, Iss 1, Pp 1-8 (2019)
AMB Express
AMB Express
Alizarin is an anti-fungal compound produced by the plant, Rubia tinctorum. The parasitic fungus Bjerkandera adusta Dec 1 was cultured in potato dextrose (PD) medium with or without alizarin. Alizarin was a good substrate for the dye-decolorizing per
Autor:
Tomomi Narioka, Mifumi Morita, Toru Yoshida, Yasushi Sugano, Kanako Sugawara, Yuriko Nishihashi
Publikováno v:
Journal of bioscience and bioengineering. 123(4)
DyP-type peroxidases are a heme peroxidase family with unique properties whose members are widely distributed from prokaryotes to eukaryotes. DyP-type peroxidases are subdivided into class P, I and V based on structure-based sequence alignment. Class
Autor:
Teruo Kitagawa, Nobuyuki Ishige, Takashi Kodama, Toshihiro Suzuki, Toya Ohashi, Hitoshi Sakuraba, Kanako Sugawara, Tadayasu Togawa, Takahiro Tsukimura, Ken Suzuki
Publikováno v:
Molecular Genetics and Metabolism. 100:257-261
Fabry disease is an X-linked genetic disorder caused by a deficiency of α-galactosidase A (GLA) activity. As enzyme replacement therapy (ERT) involving recombinant GLAs has been introduced for this disease, a useful biomarker for diagnosis and monit
Autor:
Hitoshi Sakuraba, Kazuyoshi Ikeda, Seiji Saito, Mizuki Morita, Tadayasu Togawa, Kazuki Ohno, Kanako Sugawara, Toshihiro Suzuki
Publikováno v:
Journal of Human Genetics. 54:510-515
Allelic mutations of the lysosomal beta-galactosidase gene cause heterogeneous clinical phenotypes, such as GM1 gangliosidosis and Morquio B disease, the former being further classified into three variants, namely infantile, juvenile and adult forms;
Autor:
Youichi Tajima, Seiji Saito, Kunihiko Iwamoto, Kazuki Ohno, Hitoshi Sakuraba, Kohji Itoh, Takahiro Tsukimura, Toshihide Kobayashi, Ikuo Kawashima, Kanako Sugawara
Publikováno v:
Molecular Genetics and Metabolism. 96:233-238
Enzyme enhancement therapy (EET) for Fabry disease involving imino sugars has been developed and attracted interest. It is thought that imino sugars act as pharmacological chaperones for wild-type and mutant alpha-galactosidases (GLAs) in cells, but
Autor:
Masatoshi SHIMIZU, Kanako SUGAWARA, Fumie OZAKI, Yoshihiro HAMA, Michio NISHIMURA, Hironori YOSHINO
Publikováno v:
Journal of Life Support Engineering. 21:18-23
Autor:
Arnold J. J. Reuser, Kazuki Ohno, Seiji Saito, Masakazu Sekijima, Youichi Tajima, Kanako Sugawara, Hitoshi Sakuraba, Marian A. Kroos
Publikováno v:
Journal of Human Genetics, 54(6), 324-330. Nature Publishing Group
To elucidate the mechanism underlying transport and processing defects from the viewpoint of enzyme folding, we constructed three-dimensional models of human acid a-glucosidase encompassing 27 relevant amino acid substitutions by means of homology mo
Autor:
Masatoshi Shimizu, Kanako Sugawara, Fumie Ozaki, Yoshihiro Hama, Michio Nishimura, Hironori Yoshino
Publikováno v:
Journal of Life Support Engineering. 21:110-117